Literature DB >> 33674915

Prevalence of Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis Among US Adults with Prediabetes and Diabetes, NHANES 2017-2018.

Donghee Kim1, George Cholankeril2, Rohit Loomba3,4, Aijaz Ahmed2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33674915      PMCID： PMC8738798          DOI： 10.1007/s11606-021-06677-w

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  5 in total

1.  Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Mohammad S Siddiqui; Raj Vuppalanchi; Mark L Van Natta; Erin Hallinan; Kris V Kowdley; Manal Abdelmalek; Brent A Neuschwander-Tetri; Rohit Loomba; Srinivasan Dasarathy; Danielle Brandman; Edward Doo; James A Tonascia; David E Kleiner; Naga Chalasani; Arun J Sanyal
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-26       Impact factor: 11.382

2.  Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia.

Authors:  Miquel Serra-Burriel; Isabel Graupera; Pere Torán; Maja Thiele; Dominique Roulot; Vincent Wai-Sun Wong; Indra Neil Guha; Núria Fabrellas; Anita Arslanow; Carmen Expósito; Rosario Hernández; Grace Lai-Hung Wong; David Harman; Sarwa Darwish Murad; Aleksander Krag; Guillem Pera; Paolo Angeli; Peter Galle; Guruprasad P Aithal; Llorenç Caballeria; Laurent Castera; Pere Ginès; Frank Lammert
Journal:  J Hepatol       Date:  2019-08-27       Impact factor: 25.083

3.  The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.

Authors:  Zobair M Younossi; Pegah Golabi; Leyla de Avila; James Minhui Paik; Manirath Srishord; Natsu Fukui; Ying Qiu; Leah Burns; Arian Afendy; Fatema Nader
Journal:  J Hepatol       Date:  2019-07-04       Impact factor: 25.083

4.  Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Peter J Eddowes; Magali Sasso; Michael Allison; Emmanouil Tsochatzis; Quentin M Anstee; David Sheridan; Indra N Guha; Jeremy F Cobbold; Jonathan J Deeks; Valérie Paradis; Pierre Bedossa; Philip N Newsome
Journal:  Gastroenterology       Date:  2019-01-25       Impact factor: 22.682

Review 5.  Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Laurent Castera; Mireen Friedrich-Rust; Rohit Loomba
Journal:  Gastroenterology       Date:  2019-01-18       Impact factor: 22.682
  5 in total
  4 in total

1.  Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease.

Authors:  Diana Barb; Enrico M Repetto; Michael E Stokes; Sudha S Shankar; Kenneth Cusi
Journal:  Obesity (Silver Spring)       Date:  2021-09-23       Impact factor: 9.298

2.  Nonalcoholic Fatty Liver Disease Underdiagnosis in Primary Care: What Are We Missing?

Authors:  Ellen M Nielsen; Kathryn P Anderson; Justin Marsden; Jingwen Zhang; Andrew D Schreiner
Journal:  J Gen Intern Med       Date:  2021-11-23       Impact factor: 6.473

3.  The association of weight gain with nonalcoholic fatty liver disease and fibrosis detected by FibroScan in the United States.

Authors:  Karn Wijarnpreecha; Elizabeth S Aby; Aijaz Ahmed; Donghee Kim
Journal:  Ann Gastroenterol       Date:  2022-02-15

4.  Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017-2018 transient elastography data and application of machine learning.

Authors:  Mazen Noureddin; Fady Ntanios; Deepa Malhotra; Katherine Hoover; Birol Emir; Euan McLeod; Naim Alkhouri
Journal:  Hepatol Commun       Date:  2022-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.